Prostate Cancer clinical trials
Showing 651–700 of 735 active trials. Describe your situation to see which ones you may be eligible for.
- [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
- IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
- Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer
- Pilot Feasibility Study of a Dyadic Culinary Nutrition Intervention
- Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
- RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.
- Perspectives About Online Information
- Expanding Genetic Access for Prostate Cancer Survivors
- LTFU for All Cell and Gene Therapy Studies
- Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients
- A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
- Analyzing Clinical Trial Experiences of Prostate Cancer Patients
- Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
- Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor
- Sexual Health Communication Skills Training Intervention for Patients With Prostate Cancer
- RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer)
- SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial
- Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
- A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
- Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
- iCCARE Project #4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer
- Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
- COQ10 and Vitamin E for Off-Target Radiation Toxicity
- Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
- Facilitators and Barriers to Cancer Treatment Among Texas Residents
- Sexual and Urinary Function Improvement for Cancer Survivors
- Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol
- Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer
- Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
- Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain
- A Study of Optical Fusion Trans-Perineal Grid
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
- Fusion Guided Focal Laser Ablation of Prostate Cancer
- Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer
- HIFEM Technology for Post-Radical Prostatectomy and Post-Holmium Laser Prostate Surgery
- Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men
- Genetic Education in BRCA Families
- Natural History Study of Early Life Exposures in Agriculture (ELEA)
- Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
- KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice
- Clinical Trial to Treat Stage IV Cancer Patients
- Quest to Analyze One Thousand Humans Meditating
- Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
- A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
- Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer
- Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
- Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer
- Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
- High-Risk Metachronous Oligometastatic Prostate Cancer Trial
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.